Lpl Financial LLC Ocugen, Inc. Transaction History

Lpl Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$1.11 - $1.87 $333 - $561	-300 Reduced 2.75%	10,590 $13,000
Q3 2022 Nov 14, 2022	SELL	$1.75 - $3.1 $5,372 - $9,517	-3,070 Reduced 21.99%	10,890 $19,000
Q2 2022 Aug 12, 2022	SELL	$1.83 - $3.45 $457 - $862	-250 Reduced 1.76%	13,960 $32,000
Q1 2022 May 16, 2022	SELL	$2.34 - $4.72 $19,314 - $38,958	-8,254 Reduced 36.74%	14,210 $47,000
Q4 2021 Feb 14, 2022	SELL	$4.38 - $15.67 $138,171 - $494,325	-31,546 Reduced 58.41%	22,464 $102,000
Q3 2021 Nov 15, 2021	BUY	$6.36 - $8.51 $254,272 - $340,229	39,980 Added 284.96%	54,010 $388,000
Q2 2021 Aug 13, 2021	SELL	$5.52 - $15.68 $147,108 - $417,872	-26,650 Reduced 65.51%	14,030 $113,000
Q1 2021 May 14, 2021	BUY	$1.66 - $15.81 $13,578 - $129,325	8,180 Added 25.17%	40,680 $276,000
Q4 2020 Feb 12, 2021	BUY	$0.28 - $2.6 $9,100 - $84,500	32,500 New	32,500 $59,000

124

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $169M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.